Advertisement
Screener

AUXILIUM PHARMACEUTICALS INC Stock-Based Compensation

AUXILIUM PHARMACEUTICALS INC Stock-Based Compensation

AUXILIUM PHARMACEUTICALS INC reported Stock-Based Compensation of $3.68 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2012-05-10

  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $3.68M, a 15.33% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $5.14M, a 15.03% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $3.84M, a 9.97% increase year-over-year.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-06-30 was $3.96M, a 14.62% decline year-over-year.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $17.28M, a 3.81% decline from fiscal 2010.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $17.96M, a 0.35% increase from fiscal 2009.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2009 was $17.90M, a 52.44% increase from fiscal 2008.
  • AUXILIUM PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2008 was $11.74M.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2012-03-31$3.68M
10-Q · filed 2012-05-10
$8.82M
derived: sum of 2 quarters · filed 2012-05-10
$12.66M
derived: sum of 3 quarters · filed 2012-05-10
$16.61M
derived: sum of 4 quarters · filed 2012-05-10
2011-12-31$5.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$8.98M
derived: sum of 2 quarters · filed 2012-02-29
$12.93M
derived: sum of 3 quarters · filed 2012-02-29
$17.28M
10-K · filed 2012-02-29
2011-09-30$3.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$7.79M
derived: sum of 2 quarters · filed 2011-11-09
$12.14M
10-Q · filed 2011-11-09
$18.19M
derived: sum of 4 quarters · filed 2012-05-10
2011-06-30$3.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02
$8.30M
10-Q · filed 2011-08-02
$14.35M
derived: sum of 3 quarters · filed 2012-05-10
$17.84M
derived: sum of 4 quarters · filed 2012-05-10
2011-03-31$4.34M
10-Q · filed 2012-05-10
$10.39M
derived: sum of 2 quarters · filed 2012-05-10
$13.88M
derived: sum of 3 quarters · filed 2012-05-10
$18.52M
derived: sum of 4 quarters · filed 2012-05-10
2010-12-31$6.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$9.54M
derived: sum of 2 quarters · filed 2012-02-29
$14.17M
derived: sum of 3 quarters · filed 2012-02-29
$17.96M
10-K · filed 2012-02-29
$17.48M
10-K · filed 2011-03-01
2010-09-30$3.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$8.12M
derived: sum of 2 quarters · filed 2011-11-09
$11.91M
10-Q · filed 2011-11-09
$16.28M
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30$4.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02
$8.42M
10-Q · filed 2011-08-02
$12.79M
derived: sum of 3 quarters · filed 2012-02-29
$16.92M
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31$3.79M
10-Q · filed 2011-05-10
$8.15M
derived: sum of 2 quarters · filed 2012-02-29
$12.29M
derived: sum of 3 quarters · filed 2012-02-29
2009-12-31$4.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
$8.50M
derived: sum of 2 quarters · filed 2012-02-29
$17.90M
10-K · filed 2012-02-29
2009-09-30$4.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08
$13.54M
10-Q · filed 2010-11-08
2009-06-30$9.40M
10-Q · filed 2010-08-06
2008-12-31$11.74M
10-K · filed 2011-03-01